Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials

References

• World Health OrganizationDepression2016 Available from: http://www.who.int/mediacentre/factsheets/fs369/en/Accessed November 25, 2016
   Google Scholar
• Ayuso-MateosJLVazquez-BarqueroJLDowrickCDepressive disorders in Europe: prevalence figures from the ODIN studyBr J Psychiatry200117930831611581110
   PubMed Web of Science ®Google Scholar
• BourdonKHRaeDSLockeBZNarrowWERegierDAEstimating the prevalence of mental disorders in U.S. adults from the Epidemiologic Catchment Area SurveyPublic Health Rep199210766636681454978
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerOThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• KesslerRCMcGonagleKAZhaoSLifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity SurveyArch Gen Psychiatry19945118198279933
   PubMed Web of Science ®Google Scholar
• ChisholmDDiehrPKnappMPatrickDTregliaMSimonGDepression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO)Br J Psychiatry200318312113112893665
   PubMed Web of Science ®Google Scholar
• KozelaMBobakMBesalaAThe association of depressive symptoms with cardiovascular and all-cause mortality in Central and Eastern Europe: prospective results of the HAPIEE studyEur J Prev Cardiol201623171839184727154591
   PubMed Web of Science ®Google Scholar
• SinyorMSchafferALevittAThe sequenced treatment alternatives to relieve depression (STAR*D) trial: a reviewCan J Psychiatry201055312613520370962
   PubMed Web of Science ®Google Scholar
• BerlimMTFleckMPTureckiGCurrent trends in the assessment and somatic treatment of resistant/refractory major depression: an overviewAnn Med200840214915918293145
   PubMed Web of Science ®Google Scholar
• CascadeEKalaliAHKennedySHReal-world data on SSRI antidepressant side effectsPsychiatry (Edgmont)2009621618
   PubMedGoogle Scholar
• SarkarPChakrabortyKMisraAShuklaRSwainSPPattern of psychotropic prescription in a tertiary care center: a critical analysisIndian J Pharmacol201345327027323833371
   PubMed Web of Science ®Google Scholar
• ChristodoulouEKadoglouNPKostomitsopoulosNValsamiGSaffron: a natural product with potential pharmaceutical applicationsJ Pharm Pharmacol201567121634164926272123
   PubMed Web of Science ®Google Scholar
• RíosJLRecioMCGinerRMMáñezSAn update review of saffron and its active constituentsPhytother Res1996103189193
   Web of Science ®Google Scholar
• AlonsoGLSalinasMRGaruoJSanchez-FernandezMAComposition of crocins and picrocrocin from Spanish saffron (Crocus satvus L.)J Food Quality200024219233
   Web of Science ®Google Scholar
• MoshiriMVahabzadehMHosseinzadehHClinical applications of saffron (Crocus sativus) and its constituents: a reviewDrug Res2014656287295
   Google Scholar
• MoosaviSMAhmadiMAminiMVazirzadehBThe effects of 40 and 80 mg hydro- alcoholic extract of Crocus sativus in the treatment of mild to moderate depressionJ Mazandaran Univer Med Sci2014241134753
   Google Scholar
• ShahmansouriNFarokhniaMAbbasiSHA randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patientsJ Affect Disord201415521622224289892
   PubMed Web of Science ®Google Scholar
• ShemshianMSadeghiAKermaniTSaffron (Crocus sativus) in the treatment of anxiety and depression: a double-blind, randomized and placebo-controlled trialClin Biochem20114413S118
   Web of Science ®Google Scholar
• GeorgiadouGTarantilisPAPitsikasNEffects of the active constituents of Crocus sativus L., crocins, in an animal model of obsessive-compulsive disorderNeurosci Lett20125281273022985509
   PubMed Web of Science ®Google Scholar
• SchmidtMBettiGHenselASaffron in phytotherapy: pharmacology and clinical usesWien Med Wochenschr200715713–1431531917704979
   PubMedGoogle Scholar
• WangYHanTZhuYAntidepressant properties of bioactive fractions from the extract of Crocus sativus LJ Nat Med2010641243019787421
   PubMed Web of Science ®Google Scholar
• De MonteCCarradoriSChimentiPNew insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studiesEur J Med Chem20148216417124904963
   PubMed Web of Science ®Google Scholar
• PaltaPSamuelLJMillerERSzantonSLDepression and oxidative stress: results from a meta-analysis of observational studiesPsychosom Med2014761121924336428
   PubMed Web of Science ®Google Scholar
• AsdaqSMInamdarMNPotential of Crocus sativus (saffron) and its constituent, crocin, as hypolipidemic and antioxidant in ratsAppl Biochem Biotechnol2010162235837219672721
   PubMed Web of Science ®Google Scholar
• PomaAFontecchioGCarlucciGChichiriccoGAnti-inflammatory properties of drugs from saffron crocusAntiinflamm Antiallergy Agents Med Chem2012111375122934747
   PubMedGoogle Scholar
• LoprestiALDrummondPDSaffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of actionHum Psychopharmacol201429651752725384672
   PubMed Web of Science ®Google Scholar
• RavindranAVBalneavesLGFaulknerGCanadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 5. Complementary and alternative medicine treatmentsCan J Psychiatry201661957658727486153
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders3rd edWashington, DCAmerican Psychiatric Association1980
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders The revision of3rd edWashington, DCAmerican Psychiatric Association1987
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Association1994
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders The revision of4th edWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders5th edWashington, DCAmerican Psychiatric Association2013
   Google Scholar
• World Health Organization (WHO)The Ninth Revision of the International Classification of Diseases and Related Health ProblemsGenevaWorld Health Organization1978
   Google Scholar
• World Health Organization (WHO)The Tenth Revision of the International Classification of Diseases and Related Health ProblemsGenevaWorld Health Organization1992
   Google Scholar
• HigginsJPGreenSCochrane Handbook for Systematic Reviews of Interventions, version 5.1.0Chichester, UKJohn Wiley & Sons2011
   Google Scholar
• ZimmermanMMartinezJHYoungDChelminskiIDalrympleKSeverity classification on the Hamilton Depression Rating ScaleJ Affect Disord2013150238438823759278
   PubMed Web of Science ®Google Scholar
• BeckATSteerRABeck depression Inventory ManualNew YorkGuildford Press1993
   Google Scholar
• CiprianiAZhouXDel GiovaneCComparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysisLancet20163881004788189027289172
   PubMed Web of Science ®Google Scholar
• FurukawaTABarbuiCCiprianiABrambillaPWatanabeNImputing missing standard deviations in meta-analyses can provide accurate resultsJ Clin Epidemiol200659171016360555
   PubMed Web of Science ®Google Scholar
• HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
   PubMed Web of Science ®Google Scholar
• EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltmanDGThe PRISMA GroupPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statementPLoS Med200967e100009719621072
   PubMed Web of Science ®Google Scholar
• Akhondzadeh BastiAMoshiriENoorbalaAAJamshidiAHAbbasiSHAkhondzadehSComparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trialProg Neuropsychopharmacol Biol Psychiatry200731243944217174460
   PubMed Web of Science ®Google Scholar
• AkhondzadehSFallah-PourHAfkhamKJamshidiAHKhalighi-CigaroudiFComparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]BMC Complement Altern Med200441215341662
   PubMedGoogle Scholar
• AkhondzadehSTahmacebi-PourNNoorbalaAACrocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trialPhytother Res200519214815115852492
   PubMed Web of Science ®Google Scholar
• GhajarANeishabouriSMVelayatiNCrocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trialPharmacopsychiatry20175015216027701683
   PubMed Web of Science ®Google Scholar
• MazidiMShemshianMMousaviSHA double-blind, randomized and placebo-controlled trial of saffron (Crocus sativus L.) in the treatment of anxiety and depressionJ Complement Integr Med201613219519927101556
   PubMedGoogle Scholar
• MoshiriEBastiAANoorbalaAACrocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trialPhytomedicine2006139–1060761116979327
   PubMed Web of Science ®Google Scholar
• NoorbalaAAAkhondzadehSTahmacebi-PourNJamshidiAHHydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trialJ Ethnopharmacol200597228128415707766
   PubMed Web of Science ®Google Scholar
• HausenblasHASahaDDubyakPJAntonSDSaffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trialsJ Integr Med201311637738324299602
   PubMedGoogle Scholar
• OkumuraYIchikuraKEfficacy and acceptability of group cognitive behavioral therapy for depression: a systematic review and meta-analysisJ Affect Disord201416415516424856569
   PubMed Web of Science ®Google Scholar
• Akhondzadeh BastiAChoreishiSANoorbalaAAAkhondzadehSHRezazadehSPetal and stigma of Crocus sativus L. in the treatment of depression: a pilot double-blind randomized trialJ Med Plants200872936
   Google Scholar
• MohamadpourAHAyatiZParizadehMRRajbaiOHosseinzadehHSafety evaluation of crocin (a constituent of saffron) tablets in healthy volunteersIran J Basic Med Sci2013161394623638291
   PubMed Web of Science ®Google Scholar
• KashaniLRaisiFSaroukhaniSSaffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled studyHum Psychopharmacol2013281546023280545
   PubMed Web of Science ®Google Scholar
• MansooriPAkhondzadehSRaisiFA randomized, double-blind, placebo-controlled study of safety of the adjunctive saffron on sexual dysfunction induced by a selective serotonin reuptake inhibitorJ Med Plants20111037121130
   Google Scholar
• ModabberniaASohrabiHNasehiAAEffect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trialPsychopharmacology2012223438138822552758
   PubMed Web of Science ®Google Scholar